• 6.5 mg black cohosh rhizome dry extract (4.5-8.5:1); Extraction agent: ethanol 60% (V/V)

• cellulose powder
• Silica, colloidal
• 19 mg lactose-1 water
• magnesium stearate
• cornstarch
• Carboxymethyl Starch, Sodium Type A
• hypromellose
• Macrogol 4000
• calcium hydrogen phosphate-2 water
• titanium dioxide
• ferric oxide
• Iron(III) oxide hydrate, black

KLIMADYNON uno film-coated tablets, menopause symptoms indication

• Herbal medicine to relieve menopausal symptoms such as hot flashes and excessive sweating.

KLIMADYNON uno film-coated tablets, menopause symptoms dosage

• Always take the medicine exactly as instructed in this leaflet. Please check with your doctor or pharmacist if you are not sure.
• Unless otherwise prescribed by the doctor, the usual dose is:
  • Adults take one film-coated tablet once a day (in the evening).

• Duration of use:
  • If your symptoms persist while taking this medicine, please see your doctor or ask your pharmacist.
  • Do not take the medicine for more than 6 months without medical advice.
  • Please talk to your doctor or pharmacist if you have the impression that the effect is too strong or too weak.

• If you take more of the medicine than you should:
  • No case of overdose has been reported. If you take more than you should, please inform your doctor. This person can decide on any necessary measures.

• If you forget to take a dose:
  • Do not take a double dose to make up for a forgotten dose.

• If you stop taking:
  • Discontinuation is usually harmless.

• If you have any further questions on the use of the medicine, ask your doctor or pharmacist.

KLIMADYNON uno film-coated tablets, menopause symptoms way

• If possible, the medicine should always be taken at the same time of day (in the evening).
• Swallow the film-coated tablet whole with some liquid.

side effects

• Like all medicines, this medicine can cause side effects, although not everyone gets them.
• The evaluation of side effects is based on the following frequency information:
  • Very common: affects more than 1 in 10 people
  • Common: affects 1 to 10 users in 100
  • Uncommon: affects 1 to 10 users in 1,000
  • Rare: affects 1 to 10 users in 10,000
  • Very rare: affects less than 1 in 10,000 people
  • Not known: frequency cannot be estimated from the available data
• Possible side effects:
  • Liver damage (e.g. liver inflammation, jaundice, disturbances in liver function tests) has occurred in connection with the use of products containing Cimicifuga.
  • Skin reactions (urticaria, itching, rash), facial edema, peripheral edema and gastrointestinal disorders (eg dyspeptic disorders, diarrhea) have been reported.
  • The frequency of these possible side effects cannot be estimated from the available data.
• If side effects occur, the drug should be discontinued and a doctor consulted.
• Please inform your doctor or pharmacist if you notice any side effects not listed in this leaflet.

interactions

• Taking/using other medicines:
  • Interactions with other drugs are not known to date.
  • Please inform your doctor or pharmacist if you are taking/using or have recently taken/used other medicines, even if they are non-prescription medicines.
• When taken with food and drink:
  • No special precautions are necessary.

Contraindications

• The medicine must not be taken:
  • if you are allergic (hypersensitive) to the active substance or any of the other ingredients.
    

pregnancy and breast feeding period

• Pregnancy and breast feeding period:
  • The safety of use during pregnancy and lactation has not been proven. Use during pregnancy and lactation is not recommended due to insufficient studies.
  • Women of childbearing potential should use effective contraception during treatment.

patient KLIMADYNON uno film-coated tablets, menopause symptoms notes

• Special care is required when taking:
  • Patients with previously damaged livers should only be used after consulting a doctor. Patients should stop taking the drug immediately and consult a doctor if signs of liver damage (fatigue, loss of appetite, yellowing of the skin and eyes, severe upper abdominal pain with nausea and vomiting, or dark urine) occur.
  • Simultaneously taking estrogens should not be done without consulting a doctor.
  • Patients who have been or are being treated for breast cancer or other hormone-dependent tumors should not take the medicine without consulting their doctor.
  • A doctor should be consulted in the event of disruptions or recurrence of menstrual bleeding, as well as persistent, unclear or newly occurring symptoms, as these may be diseases that require clarification by a doctor.
• Please consult a doctor or ask a pharmacist if symptoms worsen during treatment with the medicine.

• Driving and using machines:
  • No studies on the effects on the ability to drive and use machines have been performed.